EMD-42180
(V17) - "Mechanism of dual pharmacological correction and potentiation of human CFTR"
EMD-42180
Single-particle3.35 Å
Deposition: 02/10/2023Map released: 16/10/2024
Last modified: 16/10/2024
Sample Organism:
Homo sapiens
Sample: cystic fibrosis transmembrane conductance regulator(CFTR)
Deposition Authors: Wang C
,
Singh S ,
Loughlin BJ,
Yang Z,
Xu H,
Veit G,
Vorobiev S,
Clarke OB,
Jiang F,
Li Y,
Rich Z,
Menten ER,
Grassucci RA,
Wang W,
Mezzell A,
Fu Z,
Wong K,
Wetmore DR,
Sutton RB,
Brouillette CG,
Urbatsch IL,
Kappes JC,
Lukacs GL,
Frank J,
Hunt JF ,
Cohen BM
Sample: cystic fibrosis transmembrane conductance regulator(CFTR)
Deposition Authors: Wang C
,
Singh S ,
Loughlin BJ,
Yang Z,
Xu H,
Veit G,
Vorobiev S,
Clarke OB,
Jiang F,
Li Y,
Rich Z,
Menten ER,
Grassucci RA,
Wang W,
Mezzell A,
Fu Z,
Wong K,
Wetmore DR,
Sutton RB,
Brouillette CG,
Urbatsch IL,
Kappes JC,
Lukacs GL,
Frank J,
Hunt JF ,
Cohen BM
(N3 Consensus Map) - "Mechanism of dual pharmacological correction and potentiation of human CFTR"
Wang C ,
Singh S ,
Loughlin BJ,
Yang Z,
Xu H,
Veit G,
Vorobiev S,
Clarke OB,
Jiang F,
Li Y,
Rich Z,
Menten ER,
Grassucci RA,
Wang W,
Mezzell A,
Fu Z,
Wong K,
Wetmore DR,
Sutton RB,
Brouillette CG,
Urbatsch IL,
Kappes JC,
Lukacs GL,
Frank J,
Hunt JF ,
Cohen BM
To Be Published
,
Singh S ,
Loughlin BJ,
Yang Z,
Xu H,
Veit G,
Vorobiev S,
Clarke OB,
Jiang F,
Li Y,
Rich Z,
Menten ER,
Grassucci RA,
Wang W,
Mezzell A,
Fu Z,
Wong K,
Wetmore DR,
Sutton RB,
Brouillette CG,
Urbatsch IL,
Kappes JC,
Lukacs GL,
Frank J,
Hunt JF ,
Cohen BM
To Be Published
Grant Support:
- Cystic Fibrosis Foundation: Hunt18G0 (United States)
- Cystic Fibrosis Foundation: Hunt20G0 (United States)
- Cystic Fibrosis Foundation: HUNT13XX0 (United States)
- Cystic Fibrosis Foundation: 004400G222 (United States)
- Cystic Fibrosis Foundation: FRANK16XX0 (United States)
- Cystic Fibrosis Foundation: FRANK18G0 (United States)